Experimental Epilepsy Group
11 – 20 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
GDNF Increases Inhibitory Synaptic Drive on Principal Neurons in the Hippocampus via Activation of the Ret Pathway
(
- Contribution to journal › Article
-
Mark
Enhancing neuronal inhibition by cell and gene therapy as a novel treatment for Epilepsy
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
2022) In Journal of visualized experiments : JoVE(
- Contribution to journal › Article
- 2021
-
Mark
Meeting report : EpiXchange II brings together European epilepsy research projects to discuss latest advances
(
- Contribution to journal › Letter
-
Mark
Editorial : Gene Therapy in the CNS – Progress and Prospects for Novel Therapies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Human stem cell‐derived gabaergic interneurons establish efferent synapses onto host neurons in rat epileptic hippocampus and inhibit spontaneous recurrent seizures
(
- Contribution to journal › Article
-
Mark
Human stem cell-derived GABAergic neurons functionally integrate into human neuronal networks
(
- Contribution to journal › Article
- 2020
-
Mark
Advancing gene therapy for epilepsy. Translational pre-clinical studies with neuropeptide Y and glial cell-line derived neurotrophic factor.
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Development and Validation of CRISPR Activator Systems for Overexpression of CB1 Receptors in Neurons
(
- Contribution to journal › Article
-
Mark
Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy : Preclinical Data in Rats
(
- Contribution to journal › Article